Zusammenfassung
Synthesis and characterization of (R)-N-alpha-(2,2-diphenylacetyl)-N-(4-hydroxybenzyl)-N-omega-([2,3-H-3]-propanoyl)-argininamide ([H-3]-UR-MK114), an easily accessible tritium-labeled NPY Y-1 receptor (Y1R) antagonist C (K-B: 0.8 nM, calcium assay, HEL cells) derived from the (R)-argininamide BIBP 3226, is reported. The radioligand binds with high affinity (K-D, saturation: 1.2 nM, kinetic ...
Zusammenfassung
Synthesis and characterization of (R)-N-alpha-(2,2-diphenylacetyl)-N-(4-hydroxybenzyl)-N-omega-([2,3-H-3]-propanoyl)-argininamide ([H-3]-UR-MK114), an easily accessible tritium-labeled NPY Y-1 receptor (Y1R) antagonist C (K-B: 0.8 nM, calcium assay, HEL cells) derived from the (R)-argininamide BIBP 3226, is reported. The radioligand binds with high affinity (K-D, saturation: 1.2 nM, kinetic experiments: 1.1 nM, SK-N-MC cells) and selectivity for Y1R over Y-2, Y-4, and Y-5 receptors. The title compound is a useful pharmacological tool for the determination of Y1R ligand affinities, quantification of Y1R binding sites, and autoradiography.
Altmetric